Biological drug and drug delivery-mediated immunotherapy.
Xiao Q, Li X, Li Y, Wu Z, Xu C, Chen Z, He W.
Acta Pharm Sin B. 2021 Apr;11(4):941-960. doi: 10.1016/j.apsb.2020.12.018. Epub 2020 Dec 31.
Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children.
Ruan Y, Xie L, Zou A.
J Cancer Res Clin Oncol. 2023 Sep;149(12):10841-10850. doi: 10.1007/s00432-023-04974-x. Epub 2023 Jun 14.
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets.
Kumar AR, Devan AR, Nair B, Vinod BS, Nath LR.
Mol Biol Rep. 2021 Dec;48(12):8075-8095. doi: 10.1007/s11033-021-06752-9. Epub 2021 Oct 20.
MYC regulates the antitumor immune response through CD47 and PD-L1.
Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, Gouw AM, Baylot V, Gütgemann I, Eilers M, Felsher DW.
Science. 2016 Apr 8;352(6282):227-31. doi: 10.1126/science.aac9935. Epub 2016 Mar 10.
Detection of acute lymphoblastic leukemia using image segmentation and data mining algorithms.
Acharya V, Kumar P.
Med Biol Eng Comput. 2019 Aug;57(8):1783-1811. doi: 10.1007/s11517-019-01984-1. Epub 2019 Jun 14.
Leukemia Cutis: An Unusual Presentation of Acute Lymphoblastic Leukemia in a Child.
Jiang X, Wang W, Zhang M.
Indian J Dermatol. 2015 Nov-Dec;60(6):636. doi: 10.4103/0019-5154.169153.
Chrysophanol suppresses growth and metastasis of T cell acute lymphoblastic leukemia via miR-9/PD-L1 axis.
Yin J, Yin Q, Liang B, Mi R, Ai H, Chen L, Wei X.
Naunyn Schmiedebergs Arch Pharmacol. 2020 Feb;393(2):273-286. doi: 10.1007/s00210-019-01778-0. Epub 2019 Dec 14.
Recognition of acute lymphoblastic leukemia and lymphocytes cell subtypes in microscopic images using random forest classifier.
Mirmohammadi P, Ameri M, Shalbaf A.
Phys Eng Sci Med. 2021 Jun;44(2):433-441. doi: 10.1007/s13246-021-00993-5. Epub 2021 Mar 22.
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia.
Zhong M, Gao R, Zhao R, Huang Y, Chen C, Li K, Yu X, Nie D, Chen Z, Liu X, Liu Z, Chen S, Lu Y, Yu Z, Wang L, Li P, Zeng C, Li Y.
Cell Death Dis. 2022 Aug 2;13(8):671. doi: 10.1038/s41419-022-05123-x.
Programmed Death Ligand-1 is Frequently Expressed in Primary Acute Myeloid Leukemia and B-Acute Lymphoblastic Leukemia.
Hamdan SO, Sughayer M, Khader M, Tbakhi A, Khudirat S, Hejazi A, AlRyalat S, Bustami N, Aladily TN.
Clin Lab. 2022 Apr 1;68(4). doi: 10.7754/Clin.Lab.2021.210701.
